Jansen, E.M.; Ruigrok, M.J.R.; Suh, M.S.; Ruppel, P.M.; Cui, X.; Opsomer, L.; Sanders, N.N.; Frijlink, H.W.; Hinrichs, W.L.J.
Freeze-Drying in Sucrose Followed by Cryomilling Enables the Formulation of sa-mRNA–LNP Powders for Inhalation. Pharmaceutics 2026, 18, 121.
https://doi.org/10.3390/pharmaceutics18010121
AMA Style
Jansen EM, Ruigrok MJR, Suh MS, Ruppel PM, Cui X, Opsomer L, Sanders NN, Frijlink HW, Hinrichs WLJ.
Freeze-Drying in Sucrose Followed by Cryomilling Enables the Formulation of sa-mRNA–LNP Powders for Inhalation. Pharmaceutics. 2026; 18(1):121.
https://doi.org/10.3390/pharmaceutics18010121
Chicago/Turabian Style
Jansen, E. M., M. J. R. Ruigrok, M. S. Suh, P. M. Ruppel, Xiaole Cui, L. Opsomer, N. N. Sanders, H. W. Frijlink, and W. L. J. Hinrichs.
2026. "Freeze-Drying in Sucrose Followed by Cryomilling Enables the Formulation of sa-mRNA–LNP Powders for Inhalation" Pharmaceutics 18, no. 1: 121.
https://doi.org/10.3390/pharmaceutics18010121
APA Style
Jansen, E. M., Ruigrok, M. J. R., Suh, M. S., Ruppel, P. M., Cui, X., Opsomer, L., Sanders, N. N., Frijlink, H. W., & Hinrichs, W. L. J.
(2026). Freeze-Drying in Sucrose Followed by Cryomilling Enables the Formulation of sa-mRNA–LNP Powders for Inhalation. Pharmaceutics, 18(1), 121.
https://doi.org/10.3390/pharmaceutics18010121
